DAVIS PETER B 4
4 · NABI BIOPHARMACEUTICALS · Filed Nov 25, 2009
Insider Transaction Report
Form 4
DAVIS PETER B
Director
Transactions
- Purchase
Common stock
2009-11-23$4.98/sh+800$3,983→ 8,614 total - Purchase
Common stock
2009-11-23$4.98/sh+2,200$10,956→ 10,814 total